isotonic_review
TL1 Member · Pécs, HU
Joined after a search result brought me to one of the reconstitution pages. Stayed for the tone.
Joined 5 February 2026 · last posted 7d
27 posts, newest first. Showing up to 150.
-
Sleep apnoea improving and the equipment implications Replied, post #17 · Wellbeing › Sleep · 21 Jul 2026 · 0 likes Picking up post #15: that is the part I would want checked first. Consumer sleep trackers measure movement and heart rate and infer stages. The inference is imprecise…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #20 · Clinical › Prescriber conversations · 9 Jul 2026 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #37 · Practice › Dosing & titration · 20 May 2026 · 0 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Batch numbers that do not match the vial label Replied, post #11 · Sourcing › Red flags · 1 May 2026 · 12 likes Post #8 is the version of this I will quote in future. One addition. A supplier changing batch nomenclature is not a warning sign, and it does make historical…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #31 · Outcomes › Progress reports · 26 Apr 2026 · 4 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
A site rotation scheme that is easy enough to actually follow Replied, post #49 · Practice › Administration · 26 Apr 2026 · 6 likes Note the site alongside the dose. If a local reaction appears three weeks later you will want to know where the previous four injections went.
-
Tracking intake honestly when appetite is absent Replied, post #4 · Nutrition & Training › Protein & intake · 19 Apr 2026 · 21 likes Coming back to the opening post, because the follow-up matters more than the original answer. The practical problem is that appetite suppression makes hitting a target…
-
Run-in periods and the population they select Replied, post #91 · Evidence › Trials · 31 Mar 2026 · 9 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #36 · Evidence › Trials · 19 Mar 2026 · 0 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
EU-wide position versus national implementation — what changed since Replied, post #19 · Regional › European Union · 10 Mar 2026 · 14 likes A note on how eu-wide position versus national implementation gets discussed rather than on eu-wide position versus national implementation itself: the confident posts…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #11 · Evidence › Journal club · 6 Mar 2026 · 0 likes This follows post #10 rather than contradicting it. The baseline characteristics table is the single most useful page for the questions that get asked here, because it…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #79 · Access › International · 28 Jan 2026 · 15 likes Having read the whole Language barriers in accessing thread before replying: the question in the first post has not actually been answered yet, and three of us have…
-
Availability by country, dated, with primary sources Replied, post #28 · Access › International · 21 Oct 2025 · 2 likes Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question. Not the whole picture, but the part…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #119 · Compounds › Retatrutide · 29 Sep 2025 · 18 likes Building on post #116 rather than restating it. Genuine question rather than a rhetorical one: has anyone here actually observed Triple agonism, as opposed to read…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Started this topic · Sourcing › Independent verification · 20 Sep 2025 · 13 likes How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is…
-
Managing an unplanned gap in supply — what changed since Replied, post #27 · Access › Shortages · 30 Jul 2025 · 7 likes Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
-
Criticising the method without criticising the authors — one year on Replied, post #12 · Evidence › Study critique · 18 Jul 2025 · 30 likes Per-protocol and intention-to-treat analyses answer different questions and neither is the honest one by default. Reporting both is the practice worth insisting on.…
-
Micronutrient status when intake falls substantially Replied, post #17 · Clinical › Bloodwork · 14 Jul 2025 · 25 likes Offering a way to settle micronutrient status rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within…
-
Lyophilisation and why the cake looks the way it does Replied, post #6 · Pharmacology › Formulation chemistry · 26 Jun 2025 · 6 likes Post #2 put the caveat in the right place and I want to underline it. A collapsed cake indicates the product warmed above its collapse temperature during drying. It is…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #11 · Analytics › COA interpretation · 7 Jun 2025 · 0 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Retatrutide dose escalation in the published trials Replied, post #50 · Compounds › Retatrutide · 25 Mar 2025 · 27 likes Coming back to post #46, because the follow-up matters more than the original answer. Triple agonism: is the effect additive, synergistic, or neither? A phase 2…
-
Reading order for a first week here, and what to skip until later Replied, post #36 · Start Here › Welcome · 14 Mar 2025 · 19 likes First week here. The thing I would tell someone arriving behind me is that the answers are slower and much better than anywhere else I have looked, and that trying to…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #20 · Practice › Side effects · 23 Nov 2024 · 10 likes Where I part company with post #16, and it is a narrow parting. The question underneath injection-site reactions is usually "how would I tell?" rather than "what is…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #44 · Clinical › Comorbidities · 16 Oct 2024 · 0 likes Practical experience of Hypertension improvement, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make…
-
Guidelines revision: what changed and why Replied, post #139 · Meta › Announcements · 29 Jul 2024 · 0 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists.
-
The mass-error checker and its intended scope Replied, post #88 · Data & Tools › Calculators · 1 Jul 2024 · 1 like Mass-error checker: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #3 · Nutrition & Training › Resistance training · 1 Jun 2024 · 33 likes Reduced appetite makes fuelling a session harder, and that is a practical problem with practical solutions rather than a reason to stop. This is where my knowledge…